Geroscience And The Lesson of Gilgamesh — Keith Comito at Ending Age-Related Diseases 2021 @LifespanIO
Geroscience And The Lesson of Gilgamesh — Keith Comito at Ending Age-Related Diseases 2021  @LifespanIO
Uploaded August 2021 | Updated November 2026, 4 days ago
Who was Gilgamesh, the Mesopotamian mythological hero, and what can the scientific field of overcoming age-related diseases learn from his story? Learn this and more as Keith Comito - President of Lifespan.io - speaks at the Ending Age-Related Diseases 2021 conference.

FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io

SCRIPT
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Behold Gilgamesh - the first literary epic hero - on a quest to heal the frail and the sick by finding the flower of rejuvenation. The very first "Hero's Journey" of which we're all still a part.

Our field of geroscience is accelerating rapidly. New technologies, such as blockchain, are emerging and bringing new communities to join in our work - as powerfully evinced by the recent pulse chain cryptocurrency airdrop fundraiser to support the SENS Research Foundation - raising nearly 28 million dollars from almost entirely new donors.

Advocates of our field are appearing ever more frequently on popular news shows, YouTube channels, and podcasts. Even in mainstream pop culture age-related disease and regenerative medicine have taken center stage. For example M Night Shyamalan's movie OLD, and Marvel's Falcon and the Winter Soldier - the plot of which not only centers on a serum with health-extending properties but on the issues of equitable access to life-saving therapies generally. With this attention and consequent funding comes meaningful advancements - such as improvements to CRISPR, cellular reprogramming, and senescent cell clearance.

At Lifespan.io we are both benefiting from and adding to this rising tide as well. Most recently through our successful crowdfunding of the PEARL project with AgelessRx, to evaluate dosing regimens of the medicine Rapamycin.

We continue to engage a growing percentage of the public through our news and video content, such as our weekly Lifespan News show and Science to Save the World. This year we'll follow this with PBS documentaries, more collaborations with Youtube celebrities like those we've created with @kurzgesagt and @lifenoggin , and by fiscally sponsoring the feature-length adaption of Tim Maupin's award-winning and excellent short film The Last Generation to Die.

Our Longevity Investor Network is expanding to promote investment into early stage longevity companies - and one of the public benefit corporations we support, NOVOS, recently closed a VC-backed financing round to build its platform of research-backed nutraceuticals, addressing all hallmarks of aging simultaneously, and offer biomarker tests.

We are also starting in-house research led by Dr. Oliver Medvedik, leveraging our strengths in crowdsourcing to investigate promising non-pharmacological interventions for age-related disease which lack traditional profit motives. Blockchain technologies may aid this greatly - and when paired with machine learning can facilitate the creation of biomarkers and predictors of disease to help us both shut down global pandemics and understand what affects our individual rates of aging.

The recent paper by David Sinclair, Andrew Scott, and Martin Ellison also helps us make a socioeconomic case for addressing aging - bolstering the concept of the Longevity Dividend. The NIA is funding trials for interventions that directly affect aging, and ARPA-H, or HARPA, has been proposed for 2022, with requested annual funding of 6.5 billion dollars targeting Alzheimer's and cancer.

The Alliance for Longevity Initiatives has also emerged - the first 501c4 organization with the express goal of creating social and political action to address the issues of an aging population. I am proud to be a part of it myself, and that LEAF will be serving as its fiscal sponsor.

No one can meet the enormity of this task alone, however. Over 100 000 people die every day due to the diseases of aging - one person every second, and ticking faster every day.

When Gilgamesh strode beyond the great walls of the city Uruk to overcome the diseases of aging, he did so selfishly. It was only when he returned, changed by the journey, that he sought to bring the gifts of healing to all humanity. Future generations have their eyes on us, and we must work not just in our own interests, but for the interest of all humankind. And in that spirit I welcome you to Ending Age-Related Diseases 2021. I hope you have a wonderful conference! Thank you.

HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming
a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io

#KeithComito #aging #longevity #Gilgamesh #Blockchain #Cryptocurrency #Crypto #HARPA #Kurzgesagt #LifeNoggin #DavidSinclair #EndingAgeRelatedDiseases #LifespanIO #longevitytechnology #OLD #OLD2021 #EARD
Geroscience And The Lesson of Gilgamesh — Keith Comito at Ending Age-Related Diseases 2021New Paradigms to Improve Womens Reproductive Health: Laura Minquini, Founder - AthenaDao EARD 2023Fecal Microbiota Transfer Reverses Aspects of Aging in MiceSENS Research Foundation panel -  Spotting Snake Oil in the Longevity Industry at EARD 2023No CRISPR Needed to Edit Mitochondrial DNAUnderstanding the Mechanisms of Lifespan Control: Dr. Vadim Glayshev at EARD 2023Rejuvenation Roundup Podcast - June 2022Preparing for a Longevity Future with DeSci: Todd White at EARD 2023Building A Longevity Ecosystem - Tina Woods | Lifespan.IO InterviewEARD 2023 Panel Discussion: Is Aging Truly Reversible?Aging Across Species with Epigenetic ClocksFinding Proteins That Can Meet Medical Needs and Rejuvenate Tissue - Thach Mai & Juvena Therapeutics
Lifespan Research Institute |

Geroscience And The Lesson of Gilgamesh — Keith Comito at Ending Age-Related Diseases 2021

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER